JPH0377178B2 - - Google Patents
Info
- Publication number
- JPH0377178B2 JPH0377178B2 JP57224104A JP22410482A JPH0377178B2 JP H0377178 B2 JPH0377178 B2 JP H0377178B2 JP 57224104 A JP57224104 A JP 57224104A JP 22410482 A JP22410482 A JP 22410482A JP H0377178 B2 JPH0377178 B2 JP H0377178B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- phe
- peptide
- residue
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001413 amino acids Chemical class 0.000 claims description 10
- 150000001261 hydroxy acids Chemical group 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000006294 amino alkylene group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 35
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 238000004587 chromatography analysis Methods 0.000 description 9
- -1 2-substituted malonyl residues Chemical group 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000012535 impurity Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- 125000001721 carboxyacetyl group Chemical group 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 6
- 230000004071 biological effect Effects 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 239000011261 inert gas Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 239000012948 isocyanate Substances 0.000 description 4
- 150000002513 isocyanates Chemical class 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 108010002156 Depsipeptides Proteins 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- CQIUZHAQYHXKRY-VIFPVBQESA-N (2s)-2-amino-3-phenylpropanal Chemical compound O=C[C@@H](N)CC1=CC=CC=C1 CQIUZHAQYHXKRY-VIFPVBQESA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000003488 releasing hormone Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 238000006969 Curtius rearrangement reaction Methods 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KKJQZEWNZXRJFG-UHFFFAOYSA-N L-trans-4-Methyl-2-pyrrolidinecarboxylic acid Chemical compound CC1CNC(C(O)=O)C1 KKJQZEWNZXRJFG-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
- 239000004157 Nitrosyl chloride Substances 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102100029251 Phagocytosis-stimulating peptide Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102400000096 Substance P Human genes 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 108010084754 Tuftsin Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical class C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- RIGIWEGXTTUCIQ-UHFFFAOYSA-N hydroxy-imino-diphenyl-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1P(=O)(N)C1=CC=CC=C1 RIGIWEGXTTUCIQ-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- WHQSYGRFZMUQGQ-UHFFFAOYSA-N n,n-dimethylformamide;hydrate Chemical compound O.CN(C)C=O WHQSYGRFZMUQGQ-UHFFFAOYSA-N 0.000 description 1
- VPCDQGACGWYTMC-UHFFFAOYSA-N nitrosyl chloride Chemical compound ClN=O VPCDQGACGWYTMC-UHFFFAOYSA-N 0.000 description 1
- 235000019392 nitrosyl chloride Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical group O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- HMJQKIDUCWWIBW-PVQJCKRUSA-N trifluoroalanine Chemical compound OC(=O)[C@@H](N)C(F)(F)F HMJQKIDUCWWIBW-PVQJCKRUSA-N 0.000 description 1
- IESDGNYHXIOKRW-LEOABGAYSA-N tuftsin Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-LEOABGAYSA-N 0.000 description 1
- 229940035670 tuftsin Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- WHNFPRLDDSXQCL-UHFFFAOYSA-N α-melanotropin Chemical compound C=1N=CNC=1CC(C(=O)NC(CC=1C=CC=CC=1)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)NC(CCCCN)C(=O)N1C(CCC1)C(=O)NC(C(C)C)C(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(NC(=O)C(CO)NC(C)=O)CC1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãä¿è·ãããæ«ç«¯âNH2åºãŸãã¯â
OHåºãæããã¢ããé žãããããã·é žãããã
ããŸãã¯ããã·ããããæ®åºããã®äžèšäžè¬åŒ
ïŒïŒãæããâã¢ãã¢ã·ã«åãžãšã âãžã¢ã
ãèªå°äœã®æ°èŠè£œæ³ã«ä¿ããã äžè¬åŒïŒïŒ ããããã®ã¢ããçµåã®æ¹åæ§ã®è»¢æãããšãã° ãã ãžã®è»¢æã«ãããçç©æŽ»æ§ããã€ããããé¡äŒŒäœ
ãåŸãããããã®ããããé¡äŒŒäœã¯ãçç©æŽ»æ§ã«
ã€ããŠã®åŽéãšããããéªšæ Œãšã®éã®çžå¯Ÿçãªé
èŠæ§ã決å®ããç 究ã®ããã®éèŠãªç©è³ªã§ãããš
ãšãã«ãé µçŽ ã«ããæžæã«å¯ŸããŠãé«åºŠã®å®å®æ§
ãæããŠããããè¬çåŠã®åéã§ã䜿çšãããŠã
ãïŒGoodman M.ããã³Chorev M.ãã¢ã¯ã»ãã¿
ã³ã¹ã»ã±ãã«ã«ã»ãªãµãŒãïŒAcc.Chem.Res.ïŒã
12ãïŒïŒ1979ïŒããã³åŒçšæç®ïŒãå¿ èŠãªå Žåãé
äžã®ããã€ãã®ã¢ããé žæ®åºã®ãã©ãªãã€ãŒã®å
転ããã³æ«ç«¯åºã®å€æã«äŒŽãªããããã®çš®ã®ãã
ããéªšæ Œã®å€æã¯ãåŽéã®äœçžãå€åãããªãã
ãã«è¡ãªããããåŸãããé¡äŒŒäœïŒäžè¬ã«éâå
転ïŒretroâinversoïŒãããããšããŠå ¬ç¥ã§ã
ãïŒã¯æ§é ç°æ§äœã§ããããããã®ç°æ§äœã¯äœçž
ååŠçã«ã¯å€©ç¶ã®ãããããšã¯æ£ç¢ºã«ã¯äžèŽããª
ããããã®çç©æŽ»æ§ã¯ä¿æããŠãããç¹ã«ãç°ç¶
ããããããã³ããã·ããããã®å Žåã«ã¯ãéäž
ã®åãã©ã«äžå¿ã®å転ã«ãã䌎ãªããããããã
éªšæ Œã®åãã©ã«äžå¿ã®å転ã«ãã䌎ãããããã
ãéªšæ Œã®æ¹åã®å転ã«ããå åãªçç©æŽ»æ§ãæã
ãæ§é ç°æ§äœãçæããããšãç¥ãããŠãã
ïŒShemyakin M.M.ãOvchinni KOV Y.A.ãã
ã³Ivanov V.T.ãã¢ã³ã²ãã³ãã»ã±ããŒïŒAngew.
Chem.ïŒãïŒã492ïŒ1969ïŒïŒããŸãããããã®åå
ç©ã«ãããŠãçç©æŽ»æ§ã¯ããããéªšæ Œã®æ§é ãã
ã¯ãããåŽéã®äžæ¬¡å ã®æ¹åæ§ã«å·Šå³ãããããš
ãæããã§ããããã¹ãŠã®ããããçµåã転æã
ããçŽéç¶ããããã®éâå転é¡äŒŒäœã®å Žåã«
ã¯ãæ«ç«¯åºã®ååšããå¯Ÿç §ã®ãããããšã®ç«äœçž
è£æ£ïŒsteric complementarityïŒã®ç¶æã®åé¡ã
æäŸãããäžè¬ã«ãããã³ã¢ããéæ«ç«¯ããã³é
é¢ã«ã«ããã·ã«åºãæããçŽéç¶ããããã®å Žå
ã«ã¯ããã®åé¡ã¯ãâæ«ç«¯ã¢ããé žæ®åºããžãš
ã âãžã¢ããæ®åºã«å€æããããšãâæ«ç«¯ã¢ã
ãé žæ®åºããããã«æ®åºãŸãã¯ïŒäœã§çœ®æããã
ãããã«æ®åºã«å€æããããšãããã³äžéã®æ®åº
ãå転ããé 眮ããã€éã«æ¿å ¥ããããšã«ãã解
決ãããã éäžã®ããããçµåãå šéšã§ã¯ãªããéâå転
ãããå Žåã«ã¯ãå€åãããéããã€ã»ã°ã¡ã³ã
ãæ£åžžãªã»ã°ã¡ã³ãã®éã«çµèŸŒãŸããåŠãéšåç
ã«å€åãããéâå転é¡äŒŒäœãåŸãããã åäžããããçµåã®å転ã§ã¯ãã¢ããæ«ç«¯ã«è¿
ãæ®åºããžãšã âãžã¢ããã¿ã€ãã§ãããäžæ¹ã
ã«ã«ããã·ã«æ«ç«¯ã«è¿ãæ®åºããããã«ãŸãã¯ïŒ
â眮æãããã«ã¿ã€ãã§ããïŒã€ã®è¿æ¥ããéã¢
ããé žæ®åºãçæããããã®ãããªå€æãéè¿æ¥
ããããçµåãžå¿çšããããšã«ãããïŒã€ã®éã¢
ããé žæ®åºã®éã«æ¿å ¥ãããã¢ããé žã®ãã©ãªã
ã€ãŒå転ãå¯èœã«ãªãã çŸåšãŸã§ã®ãšãããã¢ã³ãžãªãã³ã·ã³ããã©ãž
ããã³ãã«ããªãããã³æŸåºãã«ã¢ã³ãåç²ç¶è º
æ§ãã«ã¢ã³æŸåºãã«ã¢ã³ããšã³ã»ãã¢ãªã³ãã¿ã
ãã·ã³ïŒtuftsinïŒãè±ã¢ããã¬ã¹ããªã³ã®ïŒ£æ«ç«¯
ããã©ãããããαâã¡ã©ããããã³ã®ïŒãïŒã
ãããããµãã¹ã¿ã³ã¹P5ã11ããã³ã¢ã¹ãã«ã¿ãŒ
ãŒã®åŠãçŽç·ç¶ã®ããããã®çç©æŽ»æ§éâå転é¡
䌌äœãåæãããŠããïŒGoissis G.ãããžã€ãŒã
ã«ã»ãªãã»ã¡ãã€ã«ã«ã»ã±ãã¹ããªãŒïŒJ.Med.
Chem.ïŒã19ã1287ïŒ1976ïŒïŒVogler K.ãããã«
ããã€ã«ã»ããã«ã»ã¢ã¯ã¿ïŒHelv.Chim.Acta.ïŒã
49ã390ïŒ1966ïŒïŒChorev M.ããããããïŒç¬¬ïŒ
åã¢ã¡ãªã«ããããã·ã³ããžãŠã ã®äŒå ±
ïŒPeptidesïŒProceedings of the ïŒ th
American Peptide SymposiumãããGoodman
M.ããã³Meienhofer J.ç·šãWiley瀟åºçãããŠ
ãŒãšãŒã¯ã1977ãããŒãž572ïŒGoodman M.ãã
ã³Chorev M.ãããŒã¹ãã¯ãã€ãã»ã€ã³ã»ããã
ãã»ã±ãã¹ããªãŒïŒPerspectives in Peptide
ChemistryïŒãEberle A.ãGeiger R.ããã³
Wieland T.ç·šãKarger瀟åºçãããŒãŒã«ã
1980ãããŒãž283ïŒChorev M.ãããµã€ãšã³ã¹
ïŒScienceïŒã204ã1210ïŒ1979ïŒïŒHayward C.F.ã
ãã³Morley J.S.ããããã1974ã第13åãšãŒã
ããããããã·ã³ããžãŠã ã®äŒå ±ïŒPeptides
1974ãProceedings of the 13th European
Peptide SymposiumïŒãVolman Y.ç·šãWiley瀟
åºçãããŠãŒãšãŒã¯ããã³ã€ã¹ã©ãšã«å€§åŠåºçã
ãšã«ãµã¬ã ã1975ãããŒãž287ïŒChung D.ããã³
Li C.H.ãããªã±ãã«ã«ã»ã¢ã³ãã»ããªãã€ãžã«
ã«ã»ã¢ã¯ã¿ïŒBiochem.Biophys.Acta.ïŒã136ã
570ïŒ1967ïŒïŒCuignet E.ããPeptide 1980ã第16
åãšãŒãããããããã·ã³ããžãŠã ã®äŒå ±ã
Brunfeldt K.ç·šã1981ãããŒãž608ïŒã ç¹ã«ãïŒçªç®ãšïŒçªç®ã®æ®åºã®éã®ããããçµ
åã®å転ã䌎ãïŒããã«åæã«æ«ç«¯ã«ã«ããã·ã¢
ããçµåã®å転ã䌎ããã®ã§ãã€ãŠãããããŸã
䌎ããªããã®ã§ããïŒãšã³ã»ãã¢ãªã³ã¢ããã®ïŒ
çš®ã®é¡äŒŒäœã®åæã«ããããšã³ã»ãã¢ãªã³ã®æ°èŠ
ã§ãã€åŒ·åãªäœçžååŠé¡äŒŒäœãçæãããŠããã ãã®å Žåãéäžã®ã¢ããçµåã®äžéšã®å転ã«ã
ããçç©æŽ»æ§ãæªå€åã®ãŸãŸä¿æãããã ãã§ãª
ããã€ã³ããã§ã®é µçŽ å æ°Žå解ã«å¯Ÿãã匷åãã
ãæµææ§ã®ããçç©æŽ»æ§ã¯å¢åŒ·ãããã ãããã«æ®åºãŸãã¯ïŒâ眮æãããã«æ®åºã®ã
ãããããããžã®çµèŸŒã¿ã§ã¯ç¹æ®ãªåé¡ç¹ãçã
ãªããããžãšã âãžã¢ããã¢ã«ãã«æ®åºã§ã¯ç¹æ®
ã§ãã€ããªã±ãŒããªåæææ³ãå¿ èŠãšããã䜿çš
ããåå¿ã®é åºã¯æ¬¡ã®ãšããã§ãããããªãã¡ã
ãŸãNH2åºã§é©åœã«ä¿è·ãããã¢ããé žãŸãã¯
ããããã¢ãžããã¯ã«ããŠã¹è»¢ç§»ã«ããçžåœãã
ã€ãœã·ã¢ããŒãã«å€ãããã€ã¥ããŠãã€ãœã·ã¢ã
ãŒããã«ã«ããã·ã«ååç©ãšã®åå¿ã«äœ¿çšããŠæ··
åããç¡æ°Žã«ã«ããã³é žâç¡æ°Žã«ã«ãã³é žïŒäºé ž
åççŽ ã®ç±é€å»ã«ããææã®ã¢ããçµåãçã
ãïŒãçæããããéå°ã®é©åœãªã¢ã«ã³ãŒã«ïŒäž
è¬ã«ç¬¬ïŒçŽã¢ã«ã³ãŒã«ãŸãã¯ãã³ãžã«ã¢ã«ã³ãŒ
ã«ïŒãšã®åå¿ã«äœ¿çšããŠãžãšã âãžã¢ããæ®åºã®
ããã®æ°ããçš®é¡ã®ãŠã¬ã¿ã³ä¿è·åºã圢æããã
ãã®çš®ã®æ°ããã¢ããä¿è·åºã¯ããžãšã âãžã¢ã
ãã¢ã«ãã«èªå°äœã®äžå®å®æ§ã®ãããã«ã«ããã·
ã«ååç©ãšã®çž®ååå¿åŸçŽã¡ã«é€å»ããã
ïŒGoodman M.ããã³Chorev M.ãã¢ã¯ã»ãã¿ã³
ã¹ã»ã±ãã«ã«ã»ãªãµãŒãã12ãïŒïŒ1979ïŒïŒãã€ãœ
ã·ã¢ããŒãã¯ã以äžã®ïŒã€ã®ç°ãªãåææ³ã«ãã
調補ãããã (a) ã«ã«ããã·ååç©ããã«ãšã³äžããžããšãã«
ãã¹ããªã«ã¢ãããšåå¿ãããã€ã¥ããŠããªãš
ãã«ã¢ãã³ååšäžã§å ç±ããããšïŒWilson C.
G.ããããããïŒç¬¬ïŒåã¢ã¡ãªã«ããããã·
ã³ããžãŠã ã®äŒå ±ãGoodman M.ããã³
Mienhofer J.ç·šãWiley瀟åºçããããŒãšãŒ
ã¯ã1977ãããŒãž579ïŒ (b) æ··åããç¡æ°Žã«ã«ããã³é žâç¡æ°Žã«ã«ãã³é ž
ãå·åŽæ¡ä»¶äžã§ãæ°Žäžãéå°ã®ã¢ãžåãããªãŠ
ã ãšåå¿ãããŠçžåœããã¢ãžåã¢ã·ã«ãšããã€
ã¥ããŠç±è»¢ç§»ãããããšïŒSheehan J.G.ã
ããžã€ãŒãã«ã»ãªãã»ãªã«ã¬ããã¯ã»ã±ãã¹ã
ãªãŒã42ã4045ïŒ1977ïŒïŒ (c) ã¢ã·ã«ããã©ãžãããç¡æ°Žã®ããã©ãããã
ã©ã³äžã§å¡©åãããã·ã«ãšåå¿ãããŠçžåœãã
ã¢ãžåç©ãšããã€ãã§ç±è»¢ç§»ãããããš
ïŒHonzl J.ããã³Rudinger J.ãã³ã¬ã¯ã·ãšã³ã»
ãªãã»ããšã³ã¹ãããã¢ã»ã±ãã«ã«ã»ã³ããŠã
ã±ãŒã·ãšã³ïŒColl.Czech.Chem.Commun.ïŒã
26ã2333ïŒ1961ïŒïŒ çºæè ãã¯ããâãã¹ïŒããªãã«ãªãã¢ã»
ããã·ïŒãšãŒããšã³ãŒã³ã䜿çšããããšã«ããã
ç¹æ®ãªååŠæäœã«ããããšãªãç¹ã«å®¹æã«ããžãš
ã âãžã¢ããæ®åºãããããéªšæ Œã«å°å ¥ã§ããæ¹
æ³ãèŠåºããæ¬çºæã«è³ã€ãããã®æ°ããè©Šè¬
ã¯ãæè¿ã§ã¯ãäžéäœã§ããã€ãœã·ã¢ããŒããå
é¢ããããšãªãã極ããŠæž©åãªåå¿æ¡ä»¶äžã«ãã
ãŠãç°¡åãªæ§é ã®ç¬¬ïŒçŽã«ã«ããã·ã«ã¢ãããçŽ
æ¥ã¢ãã³ã«å€ããéã«äœ¿çšãããŠãã
ïŒRadhakrishna A.S.ãããžã€ãŒãã«ã»ãªãã»ãª
ã«ã¬ããã¯ã»ã±ãã¹ããªãŒã44ã1746ïŒ1979ïŒïŒã çºæè ãã¯ããã®ææ³ãå¿çšãã次åŒã«åŸã€
ãŠãäžè¬åŒïŒïŒãæããæ«ç«¯âNH2åºãŸãã¯
âOHåºã§ä¿è·ããã第ïŒçŽã¢ããé žããããã
ã·é žããããããŸãã¯ããã·ããããã¢ãããã
äžè¬åŒïŒïŒã§è¡šããããâã¢ãã¢ã·ã«åãžãš
ã âãžã¢ããèªå°äœã®çžåœããããªãã«ãªãé ¢é ž
å¡©ã«çŽæ¥å€æãããããšãèŠåºããã äžèšåå¿åŒäžãã¯ãã³ãžã«ãªãã·ã«ã«ããã«
åºïŒïŒºïŒã第ïŒçŽâããã«ãªãã·ã«ã«ããã«åº
ïŒBocïŒãã¢ã·ã«æ®åºãŸãã¯äžè¬ã«åå¿æ¡ä»¶äžã§å®
å®ãªNH2ãŸãã¯OHä¿è·åºã§ãããã¯å€©ç¶ã®ã¢
ããé žãŸãã¯ããããã·é žïŒããšãã°ãããªã³ã
ã¢ã©ãã³ãããã·ã³ãã¡ããªãã³ãä¹³é žããã³ã
ã«é žãªã©ïŒãŸãã¯åæã®ã¢ããé žãŸãã¯ãããã
ã·é žïŒïŒâã¡ãã«ãããªã³ãããªãã«ãªãã¢ã©ã
ã³ãªã©ïŒã®æ®åºã§ãããã¯æ°ŽçŽ ååãŸãã¯ã¢ã«
ãã«åºãããšãã«åºãããšãã«ã¢ã«ãã¬ã³åºãã
ãããã·ããšãã«ã¢ã«ãã¬ã³åºãããããã·ã¢ã«
ãã¬ã³åºãã¢ããã¢ã«ãã¬ã³åºãã¢ã·ã«ã¢ããã¢
ã«ãã¬ã³åºãã°ã¢ããžãã«ã¢ã«ãã¬ã³åºãã€ãã
ãŸãªã«ã¢ã«ãã¬ã³åºãã€ã³ããªã«ã¢ã«ãã¬ã³åºã
ã¡ã«ã«ããã¢ã«ãã¬ã³åºãã¢ã«ãã«ã¡ã«ã«ããã¢
ã«ãã¬ã³åºãŸãã¯ã«ã«ããã·ã¢ã«ãã¬ã³åºãŸãã¯
ãããã®é©åœãªèªå°åºã§ãããïœã¯ïŒãïŒãŸãã¯
ïŒä»¥äžã§ãïŒä»¥äžã®å Žåã«ã¯ã(A)oã§è¡šãããã
ã¢ããé žã»ã¯ãšã³ã¹ã¯åäžãŸãã¯çžäºã«ç°ãªãåº
ã§æ§æãããŠããŠããããç°ãªãå Žåã«ã¯ã©ã³ã
ã ã«ãããã¯ææã®é åºã§é åãããŠããŠãã
ãããŸã(A)oã§è¡šããããã»ã¯ãšã³ã¹ã¯åäžãŸã
ã¯çžäºã«ç°ãªãã¢ããé žæ®åºããŸãã¯åäžãŸãã¯
çžäºã«ç°ãªãããããã·é žæ®åºã§æ§æãããŠããŠ
ãããããã®é åã¯ã©ã³ãã ãããã¯ææã®é åº
ã®ãããã§ãããã æ¬çºæã¯ãäžè¬çã«ã¯ãåèšäžè¬åŒïŒïŒã®ã¢
ãã³ã«æå©ã«é©çšãããåçã¯éåžž80ãªãã90ïŒ
ã§ããã åå¿ã®æé©æ¡ä»¶ãç¹ã«åå¿æéããã³è©Šè¬ã®
éãã決å®ããããã«ããã€ãããåå¿ãå©çšã
ããåæã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²ãå¹æçã«æ¹æãã
ãã€åå¿æ··åç©ã«äžæŽ»æ§ã¬ã¹ãå¹èŸŒã¿ãªããåå¿
ãå®æœãããšãããåå¿ã®å®äºãŸã§ã«ã¯ïŒãªãã
ïŒæéãèŠããã åå¿çµäºåŸãæ··åç©ãèžçºä¹Ÿåºããæ®åºãé©åœ
ãªææ©æº¶åªã§æœåºããHClãšæ··åããææ©æº¶åªã«
溶解ããååŠéè«éã®HClã§åŠçããŠãçŽæ¥ã«ãŸ
ãã¯é©åœéã®ãšãã«ãšãŒãã«ãæ·»å ããããšã«ã
ããæ«ç«¯âNH2åºãŸãã¯âOHåºã§ä¿è·ããããž
ãšã âãžã¢ããèªå°äœã®å¡©é žå¡©ãçµæ¶ãšããŠåŸã
ããããã®ããã«ããŠèª¿è£œããæçµçæç©ã¯ãç
ãéã®ããããããã³ããã·ããããïŒïŒãïŒæ®
åºïŒã®å Žåã«ã¯ããã®å¡©é žå¡©ãçµæ¶åããããšã«
ããããŸãã¯ãããè€éãªããããã®å Žåã«ã¯ã
ã¯ãããã°ã©ãã€ãŒåé¢ã«ããçŽç²ãªç¶æ ã§åé¢
ããããæ«ç«¯âNH2åºãŸãã¯âOHåºã§ä¿è·ãã
ããžãšã âãžã¢ããèªå°äœã®å¡©é žå¡©ã¯ãå·åŽæ¡ä»¶
äžã§ãäžæŽ»æ§é°å²æ°äžãæžæãçããããšãªãä¿
åãããã ã¢ããé žãŸãã¯ããããèªå°äœã§ãªãã«ã«ãã
ã·ååç©ãšã®çž®ååå¿ã«ãããŠãæ«ç«¯âNH2åº
ã§ä¿è·ããããžãšã âãžã¢ããèªå°äœã䜿çšãã
å Žåã«ã€ããŠãïŒã€ã®äŸã以äžã«äŸç€ºãããçž®å
ã«é¢äžããã«ã«ããã·ã«ã¯ãéé¢ãŸãã¯ãããã
ãã©ã°ã¡ã³ãã«çµåããã¢ããé žãŸãã¯ãããã«
æ®åºãŸãã¯ïŒâ眮æãããã«æ®åºã«é¢ä¿ãããã
ããšãã°ããžãšã âãžã¢ããèªå°äœãšåèšã«ã«ã
ãã·ã«ååç©ãšã®çž®åïŒãžã·ã¯ãããã·ã«ã«ã«ã
ãžã€ããã«ããèªçºãããã€ïŒ®âããããã·ãã³
ãŸããªã¢ãŸãŒã«ã«ãã觊åªäœçšããããïŒã¯ãäž
è¬ã«ãããããåæã«ãããå ¬ç¥ã®æ¹æ³ã«ããé«
åçã§åé¢ããããæ¬çºæã®éèŠãªç¹åŸŽã®ïŒã€
ã¯ããã®æ¹æ³ããã©ã»ãåãå®è³ªçã«å®å šã«å¶åŸ¡
ããç¶æ ã§å®æœã§ããããšã«ããã ããã«é¢ããŠãé©åœã«åæãè¡ãªããã€é«å§æ¶²
äœã¯ãããã°ã©ãã€ãŒãå©çšããŠãããããã¢ã
ãBocâPheâPheâNH2ããã³BocâPheâã»
PheâNH2ã®çžåœããé¡äŒŒäœBocâPheâgPheâ
ã»HClããã³BocâPheâgDã»Pheâã»HCl
ïŒããã§gPheã¯çžåœãããžãšã âãžã¢ããPheèª
å°äœã瀺ãïŒãžã®è»¢æãå®è³ªçãªé 眮ä¿æçïŒã©
ã»ãåã®åºŠåãéåžžã®åææ³ã§ã¯æž¬å®ãåŸãªãçš
床ïŒã§è¡ãªãããããšã確èªããã æ¬çºæã®ç®çããã³ç²Ÿç¥ã¯ä»¥äžã®å®æœäŸãæ€èš
ããããšã«ããæããã«ãªãã§ãããããã ãã
ãããã®å®æœäŸã¯çã«èª¬æããããã®ãã®ã§ãã€
ãŠãæ¬çºæãå¶éãããã®ã§ã¯ãªãã ãªããçæç©ã®çŽåºŠã«ã€ããŠã¯ã以äžã®æº¶é¢å€
ç³»(1)ã䜿çšããéçžé«å§ã¯ãããã°ã©ãã€ãŒåæ
ïŒreverse phase high pressure
chromatography analysisïŒïŒRPâHPLCïŒãã
ã³ä»¥äžã®æº¶é¢å€ç³»(2)ã䜿çšããã·ãªã«ã²ã«èå±€ã«
ããã¯ãããã°ã©ãã€ãŒåæïŒTLCïŒã«ãã枬
å®ããã 溶é¢å€ç³»(1)ïŒ H2OïŒã¢ã»ããããªã«ïŒïŒ0.01M
NH4H2PO4ïŒã¢ã»ããããªã«ïŒ0.005Mããã¿
ã³ã¹ã«ãã³é žâ0.01M NH4H2PO4ïŒã¢ã»ãã
ããªã« 溶é¢å€ç³»(2)ïŒ ãã«ãã«âãã¿ããŒã«ïŒé ¢é žïŒæ°ŽïŒïŒïŒïŒïŒ
ïŒïŒïŒã¯ãããã«ã ïŒã¡ã¿ããŒã«ïŒé ¢é žïŒ85ïŒ
10ïŒïŒïŒïŒãã«ãã«âãã¿ããŒã«ïŒã€ãœããã
ããŒã«ïŒ1N NH4OHïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒ
ïŒïŒïŒïŒã®ææ©çž èç¹ïŒM.P.ïŒã«ã€ããŠã¯è£æ£ããŠããªããã¢
ããé žããã³ãã®èªå°äœã®é 眮ã¯ãæèšããŠããª
ããšããã§ã¯ïŒ¬åœ¢ã§ããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«ââããšã
ã«ã¢ã©ãã³âãžãšã âãžã¢ããââããšãã«
ã¢ã©ãã³å¡©é žå¡©ïŒBocâPheâgPheâã»
HClïŒã®åæ BocâPheâPheâNH21åœéãã¢ã»ããããªã«
âæ°ŽïŒïŒïŒïŒïŒïŒ¶ïŒïŒ¶ïŒïŒæ··åç©äžã«æžæ¿ãããå¥
ã«ã¢ã»ããããªã«äžã«æº¶è§£ããïŒïŒ©âãã¹ïŒã
ãªãã«ãªãã¢ã»ããã·ïŒãšãŒããã³ãŒïŒBTIïŒ
1.2åœéãåèšæžæ¿æ¶²ã«å®€æž©ã§æ¿ããæ¹æããªã
ãæ·»å ããã åå¿äžã«çºçããäºé žåççŽ ã®é€å»ãä¿é²ãã
ããã«ãäžæŽ»æ§ã¬ã¹ãåå¿æ··åç©äžã«å¹èŸŒãã ã
BocâPheâPheâNH2ã®æ¶å€±ã確èªããã®ã¡ã
èžçºä¹Ÿåºãããããšã«ãããBTIã®æ·»å ããçŽïŒ
æéåŸã«åå¿ãåæ¢ãããåŸãããæ®æž£ããšãã«
ãšãŒãã«ã§æŽæµãã也ç¥ããã€ãã§ãšã¿ããŒã«ã«
溶解ããããã®æº¶æ¶²ã«ãé ¢é žãšãã«ã«æº¶è§£ããå
åŠéè«éã®HClãæ·»å ããïŒæéã§BocâPheâ
gPheâã»HClã®æ²æ®¿ãå®äºããããæ²æ®¿ç©ã
åããå°éãã€ã®ãšãã«ãšãŒãã«ã§ç¹°è¿ãæŽæµ
ããæžå§äžãP2O5ã§ä¹Ÿç¥ããååããã M.P.ïŒ174âïŒdec.ïŒ ãαã546 22ïŒâ48.8°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ã
ã
äžïŒïŒ C22H30O3N3Clã«ã€ããŠã®å çŽ åæ çè«å€ïŒC62.94ïŒ ãH7.15ïŒ ãN10.01ïŒ æž¬å®å€ïŒC63.39ïŒ ãH7.12ïŒ ãN10.27ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã§ååæ§é ã確èªããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«ââããšã
ã«ã¢ã©ãã«âãžãšã âãžã¢ããââããšãã«
ã¢ã©ãã³å¡©é žå¡©ïŒBocâPheâïœââPheâ
ã»HClïŒã®åæ BocâPheââPheâNH21åœéãã¢ã»ããã
ãªã«âæ°ŽïŒïŒïŒïŒïŒïŒ¶ïŒïŒ¶ïŒïŒæ··åç©ã«æº¶è§£ããã
ã®æº¶æ¶²ã«ã宀枩ã§ãæ¿ããæ¹æããªãããã¢ã»ã
ãããªã«ã«æº¶è§£ããBTI1.2åœéãæ·»å ãããå
å¿äžã«çºçããäºé žåççŽ ã®é€å»ã容æãªãã®ãš
ããããããã®æº¶æ¶²äžã«äžæŽ»æ§ã¬ã¹ãå¹èŸŒãã ã
ïŒæéåŸãåæã¢ããã®æ¶å€±ã確èªããã®ã¡ã溶
åªæ··åç©ãçå»ããŠä¹Ÿåºãããããšã«ããåå¿ã
åæ¢ããæ®æž£ããšãã«ãšãŒãã«ã§æŽæµãã也ç¥
ãããšã¿ããŒã«ã«æº¶è§£ããããã®æº¶æ¶²ã«ãé ¢é žãš
ãã«ã«æº¶è§£ããååŠéè«éã®HClãæ·»å ãããã®
åŸãå·åŽæ¡ä»¶äžã§ãšãã«ãšãŒãã«ãé©éæ·»å ãã
ææã®çæç©ãçµæ¶ã®åœ¢ã§åŸãã M.P.ïŒ131ã133âïŒdec.ïŒ ãαã546 20ïŒ52.0°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ãã
äžïŒïŒ C22H30O3N3Clã«ã€ããŠã®å çŽ åæ çè«å€ïŒC62.94ïŒ ãH7.15ïŒ ãN10.01ïŒ æž¬å®å€ïŒC62.58ïŒ ãH7.00ïŒ ãN9.91ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã«ããååæ§é ã確èªããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«ââã¢ã©ã
ã«âãžãšã âãžã¢ããââããšãã«ã¢ã©ãã³
å¡©é žå¡©ïŒBocâAlaâgPheâã»HClïŒã®åæ BocâAlaâPheâNH21åœéãã¢ã»ããããªã«
âæ°ŽïŒïŒïŒïŒïŒïŒ¶ïŒïŒ¶ïŒïŒæ··åç©ã«æº¶è§£ãããã®æº¶
液ã«ã宀枩ã§æ¿ããæ¹æããªãããã¢ã»ããããª
ã«ã«æº¶è§£ããBTI1.2åœéãæ·»å ãããåå¿äž
ïŒçŽïŒæéïŒãåå¿å®¹åšã«äžæŽ»æ§ã¬ã¹ãäŸçµŠããçº
çããäºé žåççŽ ã®é€å»ãè¯å¥œãªãã®ãšããã
BocâAlaâPheâNH2ã®æ¶å€±ã確èªããã®ã¡ã
åå¿æº¶åªãçå»ããæ®æž£ãé ¢é žãšãã«ã«æº¶è§£ãã
é ¢é žãšãã«ã«æº¶è§£ããååŠéè«éã®HClã§åŠçã
ããåŸãããæ²æ®¿ç©ãåããå°éã®ãšãã«ãšãŒ
ãã«ã§æŽæµããæžå§äžãP2O5ã®ååšäžã§ä¹Ÿç¥ã
ãããã®çæç©ããšã¿ããŒã«ã«æº¶è§£ããããšãã«
ãšãŒãã«ãæ·»å ããå®å šã«çµæ¶åãè¡ãªããããŸ
ã§çŽïŒâã«ç¶æããããšã«ããã極埮éã®äžçŽç©
ãŸã§é€å»ããã M.P.ïŒ137âïŒdec.ïŒ ãαã546 20ïŒ37.0°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ãã
äžïŒïŒ C16H26N3O3Clã«ã€ããŠã®å çŽ åæ çè«å€ïŒC55.90ïŒ ãH7.57ïŒ ãN12.23ïŒ æž¬å®å€ïŒC55.45ïŒ ãH7.30ïŒ ãN11.05ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã«ããååæ§é ã確èªããã å®æœäŸ ïŒ ãã³ãžã«ãªãã·ã«ã«ããã«âããšãã«ã¢ã©ãã«
âãžãšã âãžã¢ããâããšãã«ã¢ã©ãã³å¡©é žå¡©
ïŒïŒºââPheâïœã»Pheâã»HClïŒã®åæ BTI1.2åœéãæ°Žâãžã¡ãã«ãã«ã ã¢ããæ··å
ç©ïŒïŒïŒïŒïŒïŒ¶ïŒïŒ¶ïŒïŒããŸãã¯ïŒïŒ ããªãã«ãªã
é ¢é žæ°Žæº¶æ¶²âãžã¡ãã«ãã«ã ã¢ããæ··åç©ïŒïŒïŒ
ïŒïŒïŒ¶ïŒïŒ¶ïŒïŒãã«æº¶è§£ããããã®æº¶æ¶²ã«ããžã¡ã
ã«ãã«ã ã¢ããã«æº¶è§£ããâPheâPheâ
NH21åœéãæ·»å ãããåå¿äžïŒçŽïŒæéïŒãäž
掻æ§ã¬ã¹ãå¹èŸŒã¿ãçæããäºé žåççŽ ã®é€å»ã
容æãªãã®ãšãããâPheâPheâNH2ã®æ¶å€±
ã確èªããã®ã¡ã溶åªæ··åç©ãçå»ããããšã«ã
ãåå¿ãåæ¢ããæ²¹ç¶æ®æž£ããšãã«ãšãŒãã«ã§æ°
åæŽæµããæžå§çã«ãããŠP2O5ã§ä¹Ÿç¥ããåã³
ã¡ã¿ããŒã«ã«æº¶è§£ãããæ°Žã«æº¶è§£ããååŠéè«é
ã®HClãæ·»å ããããšã«ãããææã®çæç©ãæ²
殿ãããããšãã«ãšãŒãã«ã§ç¹°è¿ãæŽæµããã®
ã¡ãæçµçæç©ãæžå§äžãP2O5ã§ä¹Ÿç¥ããåå
ããã M.P.ïŒ147âïŒdec.ïŒ ãαã546 20ïŒ65.2°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ãã
äžïŒïŒ C25H28N3O3Clã«ã€ããŠã®å çŽ åæ çè«å€ïŒC66.16ïŒ ãH6.17ïŒ ãN9.26ïŒ æž¬å®å€ïŒC65.80ïŒ ãH6.09ïŒ ãN9.14ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã«ããååæ§é ã確èªããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«âã¢ã©ãã«â
ãžãšã âãžã¢ããâããšãã«ã¢ã©ãã«ââã
ãšãã«ã¢ã©ãã³âãã³ãžã«ãªãã·ã«ã«ããã«
ïŒBocâAlaâgPheââPheâïŒã®åæ ââPhe1.1åœéããžã¡ãã«ãã«ã ã¢ããã«
æ·»å ãããã®æº¶æ¶²ã氷济ã§å·åŽããã€ãã§ããã®
溶液ã«ããžã¡ãã«ãã«ã ã¢ããã«æº¶è§£ããâã
ãããã·ãã³ãŸããªã¢ãŸãŒã«1.5åœéããã³ãã
ã©ããããã©ã³ã«æº¶è§£ãããžã·ã¯ãããã·ã«ã«ã«
ããžã€ãã1.1åœéãæ·»å ããã20ååŸããã®æ··
åç©ã«ãBocâAlaâgPheâã»HCl1.0åœéãã
ã³ïŒ®âã¡ãã«ã¢ã«ããªã³1.1åœéãæ·»å ãããçŽ
ïŒæéåŸã«ã氷济ãåãã¯ããããïŒæéåŸã
BocâAlaâgPheâã»HClãæ¶å€±ããŠããããš
ã確èªããã®ã¡ãåå¿æ··åç©ãéããæ®æž£ãã
ãã©ããããã©ã³ã§æŽæµããã®ã¡ãææ£ããã
液ããã³æŽæµæ¶²ãåããèžçºãããŠå®¹éçŽ10mlãš
ããéå°ã®æ°Žã§åŠçãããçœè²ã®ããŒãºç¶æ²æ®¿ã
åŸããããããåããïŒïŒ ã¯ãšã³é žæº¶æ¶²ãïŒïŒ
çé žæ°ŽçŽ ãããªãŠã 溶液ããã³æ°Žã§ç¹°è¿ãæŽæµã
ãã åŸãããçæç©ãããã©ããããã©ã³ã«æº¶è§£
ãã30ã50âç³æ²¹ãšãŒãã«ãæ·»å ããããšã«ãã
çµæ¶åããã M.P.ïŒ195ã197â ãαã546 20ïŒ9.96°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ãã
äžïŒïŒ C33H40N4O6ã«ã€ããŠã®å çŽ åæ çè«å€ïŒC67.35ïŒ ãH6.80ïŒ ãN9.52ïŒ æž¬å®å€ïŒC67.50ïŒ ãH6.92ïŒ ãN9.38ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã§ååæ§é ã確èªããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«âããšãã«ã¢
ã©ãã«âãžãšã âãžã¢ããââããšãã«ã¢ã©
ãã«âïœâã°ãªã·ã«âãã€ã·ã«ã¡ããªãã³ã¢ã
ãïŒBocâPheâgPheâmGlyâLeuâMetâ
NH2ïŒã®åæ HOOCâCH2âCOâLeuâMetâNH2ïŒHOâ
mGlyâLeuâMetâNH2ïŒïŒåœéãããã©ãã
ããã©ã³ã«æº¶è§£ãããã®æº¶æ¶²ã氷济ã§å·åŽããã€
ãã§ãã®æº¶æ¶²ã«ããžã¡ãã«ãã«ã ã¢ããã«æº¶è§£ã
ãâããããã·ãã³ãŸããªã¢ãŸãŒã«1.5åœéã
ãã³ããã©ããããã©ã³ã«æº¶è§£ãããžã·ã¯ããã
ã·ã«ã«ã«ããžã€ãã1.1åœéãæ·»å ããã 20ååŸããã®å·åŽããæ··åç©ã«ãBocâPheâ
gPheâã»HCl1.0åœéããã³ïŒ®âã¡ãã«ã¢ã«ã
ãªã³1.1åœéãæ·»å ãããçŽïŒæéåŸã«æ°·æµŽãå
ãå€ããæ··åç©ã宀枩ã§ïŒå€åå¿ããããæ²æ®¿ç©
ãéããããã©ããããã©ã³ã§æŽæµããã®ã¡ã
液ããã³æŽæµæ¶²ãåããçŽ10mlãšãªããŸã§æ¿çž®
ããã€ã¥ããŠéå°éã®æ°Žã§åŠçããããšã«ããã
çœè²ã®ãã¬ãŒã¯ç¶æ²æ®¿ç©ãåŸããæ²æ®¿ç©ãå
ããïŒïŒ ã¯ãšã³é žæº¶æ¶²ãïŒïŒ çé žæ°ŽçŽ ãããªãŠã
溶液ããã³æ°Žã§æŽæµãããæžå§äžãP2O5ã§ä¹Ÿç¥
ããã®ã¡ãåºç¶æ®æž£ãããã«ãšãã«ãšãŒãã«ã§æŽ
æµãã也ç¥åŸãååããã M.P.ïŒ242ã245â ãαã546 20ïŒ12.33°ïŒïŒ£ïŒ0.74ïŒãžã¡ãã«ãã«ã ã¢ã
ã
äžïŒïŒ C36H52N6O7Sã«ã€ããŠã®å çŽ åæ çè«å€ïŒC60.67ïŒ ãH7.30ïŒ ãN11.80ïŒ æž¬å®å€ïŒC60.35ïŒ ãH7.09ïŒ ãN11.69ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã«ããååæ§é ã確èªããã
OHåºãæããã¢ããé žãããããã·é žãããã
ããŸãã¯ããã·ããããæ®åºããã®äžèšäžè¬åŒ
ïŒïŒãæããâã¢ãã¢ã·ã«åãžãšã âãžã¢ã
ãèªå°äœã®æ°èŠè£œæ³ã«ä¿ããã äžè¬åŒïŒïŒ ããããã®ã¢ããçµåã®æ¹åæ§ã®è»¢æãããšãã° ãã ãžã®è»¢æã«ãããçç©æŽ»æ§ããã€ããããé¡äŒŒäœ
ãåŸãããããã®ããããé¡äŒŒäœã¯ãçç©æŽ»æ§ã«
ã€ããŠã®åŽéãšããããéªšæ Œãšã®éã®çžå¯Ÿçãªé
èŠæ§ã決å®ããç 究ã®ããã®éèŠãªç©è³ªã§ãããš
ãšãã«ãé µçŽ ã«ããæžæã«å¯ŸããŠãé«åºŠã®å®å®æ§
ãæããŠããããè¬çåŠã®åéã§ã䜿çšãããŠã
ãïŒGoodman M.ããã³Chorev M.ãã¢ã¯ã»ãã¿
ã³ã¹ã»ã±ãã«ã«ã»ãªãµãŒãïŒAcc.Chem.Res.ïŒã
12ãïŒïŒ1979ïŒããã³åŒçšæç®ïŒãå¿ èŠãªå Žåãé
äžã®ããã€ãã®ã¢ããé žæ®åºã®ãã©ãªãã€ãŒã®å
転ããã³æ«ç«¯åºã®å€æã«äŒŽãªããããã®çš®ã®ãã
ããéªšæ Œã®å€æã¯ãåŽéã®äœçžãå€åãããªãã
ãã«è¡ãªããããåŸãããé¡äŒŒäœïŒäžè¬ã«éâå
転ïŒretroâinversoïŒãããããšããŠå ¬ç¥ã§ã
ãïŒã¯æ§é ç°æ§äœã§ããããããã®ç°æ§äœã¯äœçž
ååŠçã«ã¯å€©ç¶ã®ãããããšã¯æ£ç¢ºã«ã¯äžèŽããª
ããããã®çç©æŽ»æ§ã¯ä¿æããŠãããç¹ã«ãç°ç¶
ããããããã³ããã·ããããã®å Žåã«ã¯ãéäž
ã®åãã©ã«äžå¿ã®å転ã«ãã䌎ãªããããããã
éªšæ Œã®åãã©ã«äžå¿ã®å転ã«ãã䌎ãããããã
ãéªšæ Œã®æ¹åã®å転ã«ããå åãªçç©æŽ»æ§ãæã
ãæ§é ç°æ§äœãçæããããšãç¥ãããŠãã
ïŒShemyakin M.M.ãOvchinni KOV Y.A.ãã
ã³Ivanov V.T.ãã¢ã³ã²ãã³ãã»ã±ããŒïŒAngew.
Chem.ïŒãïŒã492ïŒ1969ïŒïŒããŸãããããã®åå
ç©ã«ãããŠãçç©æŽ»æ§ã¯ããããéªšæ Œã®æ§é ãã
ã¯ãããåŽéã®äžæ¬¡å ã®æ¹åæ§ã«å·Šå³ãããããš
ãæããã§ããããã¹ãŠã®ããããçµåã転æã
ããçŽéç¶ããããã®éâå転é¡äŒŒäœã®å Žåã«
ã¯ãæ«ç«¯åºã®ååšããå¯Ÿç §ã®ãããããšã®ç«äœçž
è£æ£ïŒsteric complementarityïŒã®ç¶æã®åé¡ã
æäŸãããäžè¬ã«ãããã³ã¢ããéæ«ç«¯ããã³é
é¢ã«ã«ããã·ã«åºãæããçŽéç¶ããããã®å Žå
ã«ã¯ããã®åé¡ã¯ãâæ«ç«¯ã¢ããé žæ®åºããžãš
ã âãžã¢ããæ®åºã«å€æããããšãâæ«ç«¯ã¢ã
ãé žæ®åºããããã«æ®åºãŸãã¯ïŒäœã§çœ®æããã
ãããã«æ®åºã«å€æããããšãããã³äžéã®æ®åº
ãå転ããé 眮ããã€éã«æ¿å ¥ããããšã«ãã解
決ãããã éäžã®ããããçµåãå šéšã§ã¯ãªããéâå転
ãããå Žåã«ã¯ãå€åãããéããã€ã»ã°ã¡ã³ã
ãæ£åžžãªã»ã°ã¡ã³ãã®éã«çµèŸŒãŸããåŠãéšåç
ã«å€åãããéâå転é¡äŒŒäœãåŸãããã åäžããããçµåã®å転ã§ã¯ãã¢ããæ«ç«¯ã«è¿
ãæ®åºããžãšã âãžã¢ããã¿ã€ãã§ãããäžæ¹ã
ã«ã«ããã·ã«æ«ç«¯ã«è¿ãæ®åºããããã«ãŸãã¯ïŒ
â眮æãããã«ã¿ã€ãã§ããïŒã€ã®è¿æ¥ããéã¢
ããé žæ®åºãçæããããã®ãããªå€æãéè¿æ¥
ããããçµåãžå¿çšããããšã«ãããïŒã€ã®éã¢
ããé žæ®åºã®éã«æ¿å ¥ãããã¢ããé žã®ãã©ãªã
ã€ãŒå転ãå¯èœã«ãªãã çŸåšãŸã§ã®ãšãããã¢ã³ãžãªãã³ã·ã³ããã©ãž
ããã³ãã«ããªãããã³æŸåºãã«ã¢ã³ãåç²ç¶è º
æ§ãã«ã¢ã³æŸåºãã«ã¢ã³ããšã³ã»ãã¢ãªã³ãã¿ã
ãã·ã³ïŒtuftsinïŒãè±ã¢ããã¬ã¹ããªã³ã®ïŒ£æ«ç«¯
ããã©ãããããαâã¡ã©ããããã³ã®ïŒãïŒã
ãããããµãã¹ã¿ã³ã¹P5ã11ããã³ã¢ã¹ãã«ã¿ãŒ
ãŒã®åŠãçŽç·ç¶ã®ããããã®çç©æŽ»æ§éâå転é¡
䌌äœãåæãããŠããïŒGoissis G.ãããžã€ãŒã
ã«ã»ãªãã»ã¡ãã€ã«ã«ã»ã±ãã¹ããªãŒïŒJ.Med.
Chem.ïŒã19ã1287ïŒ1976ïŒïŒVogler K.ãããã«
ããã€ã«ã»ããã«ã»ã¢ã¯ã¿ïŒHelv.Chim.Acta.ïŒã
49ã390ïŒ1966ïŒïŒChorev M.ããããããïŒç¬¬ïŒ
åã¢ã¡ãªã«ããããã·ã³ããžãŠã ã®äŒå ±
ïŒPeptidesïŒProceedings of the ïŒ th
American Peptide SymposiumãããGoodman
M.ããã³Meienhofer J.ç·šãWiley瀟åºçãããŠ
ãŒãšãŒã¯ã1977ãããŒãž572ïŒGoodman M.ãã
ã³Chorev M.ãããŒã¹ãã¯ãã€ãã»ã€ã³ã»ããã
ãã»ã±ãã¹ããªãŒïŒPerspectives in Peptide
ChemistryïŒãEberle A.ãGeiger R.ããã³
Wieland T.ç·šãKarger瀟åºçãããŒãŒã«ã
1980ãããŒãž283ïŒChorev M.ãããµã€ãšã³ã¹
ïŒScienceïŒã204ã1210ïŒ1979ïŒïŒHayward C.F.ã
ãã³Morley J.S.ããããã1974ã第13åãšãŒã
ããããããã·ã³ããžãŠã ã®äŒå ±ïŒPeptides
1974ãProceedings of the 13th European
Peptide SymposiumïŒãVolman Y.ç·šãWiley瀟
åºçãããŠãŒãšãŒã¯ããã³ã€ã¹ã©ãšã«å€§åŠåºçã
ãšã«ãµã¬ã ã1975ãããŒãž287ïŒChung D.ããã³
Li C.H.ãããªã±ãã«ã«ã»ã¢ã³ãã»ããªãã€ãžã«
ã«ã»ã¢ã¯ã¿ïŒBiochem.Biophys.Acta.ïŒã136ã
570ïŒ1967ïŒïŒCuignet E.ããPeptide 1980ã第16
åãšãŒãããããããã·ã³ããžãŠã ã®äŒå ±ã
Brunfeldt K.ç·šã1981ãããŒãž608ïŒã ç¹ã«ãïŒçªç®ãšïŒçªç®ã®æ®åºã®éã®ããããçµ
åã®å転ã䌎ãïŒããã«åæã«æ«ç«¯ã«ã«ããã·ã¢
ããçµåã®å転ã䌎ããã®ã§ãã€ãŠãããããŸã
䌎ããªããã®ã§ããïŒãšã³ã»ãã¢ãªã³ã¢ããã®ïŒ
çš®ã®é¡äŒŒäœã®åæã«ããããšã³ã»ãã¢ãªã³ã®æ°èŠ
ã§ãã€åŒ·åãªäœçžååŠé¡äŒŒäœãçæãããŠããã ãã®å Žåãéäžã®ã¢ããçµåã®äžéšã®å転ã«ã
ããçç©æŽ»æ§ãæªå€åã®ãŸãŸä¿æãããã ãã§ãª
ããã€ã³ããã§ã®é µçŽ å æ°Žå解ã«å¯Ÿãã匷åãã
ãæµææ§ã®ããçç©æŽ»æ§ã¯å¢åŒ·ãããã ãããã«æ®åºãŸãã¯ïŒâ眮æãããã«æ®åºã®ã
ãããããããžã®çµèŸŒã¿ã§ã¯ç¹æ®ãªåé¡ç¹ãçã
ãªããããžãšã âãžã¢ããã¢ã«ãã«æ®åºã§ã¯ç¹æ®
ã§ãã€ããªã±ãŒããªåæææ³ãå¿ èŠãšããã䜿çš
ããåå¿ã®é åºã¯æ¬¡ã®ãšããã§ãããããªãã¡ã
ãŸãNH2åºã§é©åœã«ä¿è·ãããã¢ããé žãŸãã¯
ããããã¢ãžããã¯ã«ããŠã¹è»¢ç§»ã«ããçžåœãã
ã€ãœã·ã¢ããŒãã«å€ãããã€ã¥ããŠãã€ãœã·ã¢ã
ãŒããã«ã«ããã·ã«ååç©ãšã®åå¿ã«äœ¿çšããŠæ··
åããç¡æ°Žã«ã«ããã³é žâç¡æ°Žã«ã«ãã³é žïŒäºé ž
åççŽ ã®ç±é€å»ã«ããææã®ã¢ããçµåãçã
ãïŒãçæããããéå°ã®é©åœãªã¢ã«ã³ãŒã«ïŒäž
è¬ã«ç¬¬ïŒçŽã¢ã«ã³ãŒã«ãŸãã¯ãã³ãžã«ã¢ã«ã³ãŒ
ã«ïŒãšã®åå¿ã«äœ¿çšããŠãžãšã âãžã¢ããæ®åºã®
ããã®æ°ããçš®é¡ã®ãŠã¬ã¿ã³ä¿è·åºã圢æããã
ãã®çš®ã®æ°ããã¢ããä¿è·åºã¯ããžãšã âãžã¢ã
ãã¢ã«ãã«èªå°äœã®äžå®å®æ§ã®ãããã«ã«ããã·
ã«ååç©ãšã®çž®ååå¿åŸçŽã¡ã«é€å»ããã
ïŒGoodman M.ããã³Chorev M.ãã¢ã¯ã»ãã¿ã³
ã¹ã»ã±ãã«ã«ã»ãªãµãŒãã12ãïŒïŒ1979ïŒïŒãã€ãœ
ã·ã¢ããŒãã¯ã以äžã®ïŒã€ã®ç°ãªãåææ³ã«ãã
調補ãããã (a) ã«ã«ããã·ååç©ããã«ãšã³äžããžããšãã«
ãã¹ããªã«ã¢ãããšåå¿ãããã€ã¥ããŠããªãš
ãã«ã¢ãã³ååšäžã§å ç±ããããšïŒWilson C.
G.ããããããïŒç¬¬ïŒåã¢ã¡ãªã«ããããã·
ã³ããžãŠã ã®äŒå ±ãGoodman M.ããã³
Mienhofer J.ç·šãWiley瀟åºçããããŒãšãŒ
ã¯ã1977ãããŒãž579ïŒ (b) æ··åããç¡æ°Žã«ã«ããã³é žâç¡æ°Žã«ã«ãã³é ž
ãå·åŽæ¡ä»¶äžã§ãæ°Žäžãéå°ã®ã¢ãžåãããªãŠ
ã ãšåå¿ãããŠçžåœããã¢ãžåã¢ã·ã«ãšããã€
ã¥ããŠç±è»¢ç§»ãããããšïŒSheehan J.G.ã
ããžã€ãŒãã«ã»ãªãã»ãªã«ã¬ããã¯ã»ã±ãã¹ã
ãªãŒã42ã4045ïŒ1977ïŒïŒ (c) ã¢ã·ã«ããã©ãžãããç¡æ°Žã®ããã©ãããã
ã©ã³äžã§å¡©åãããã·ã«ãšåå¿ãããŠçžåœãã
ã¢ãžåç©ãšããã€ãã§ç±è»¢ç§»ãããããš
ïŒHonzl J.ããã³Rudinger J.ãã³ã¬ã¯ã·ãšã³ã»
ãªãã»ããšã³ã¹ãããã¢ã»ã±ãã«ã«ã»ã³ããŠã
ã±ãŒã·ãšã³ïŒColl.Czech.Chem.Commun.ïŒã
26ã2333ïŒ1961ïŒïŒ çºæè ãã¯ããâãã¹ïŒããªãã«ãªãã¢ã»
ããã·ïŒãšãŒããšã³ãŒã³ã䜿çšããããšã«ããã
ç¹æ®ãªååŠæäœã«ããããšãªãç¹ã«å®¹æã«ããžãš
ã âãžã¢ããæ®åºãããããéªšæ Œã«å°å ¥ã§ããæ¹
æ³ãèŠåºããæ¬çºæã«è³ã€ãããã®æ°ããè©Šè¬
ã¯ãæè¿ã§ã¯ãäžéäœã§ããã€ãœã·ã¢ããŒããå
é¢ããããšãªãã極ããŠæž©åãªåå¿æ¡ä»¶äžã«ãã
ãŠãç°¡åãªæ§é ã®ç¬¬ïŒçŽã«ã«ããã·ã«ã¢ãããçŽ
æ¥ã¢ãã³ã«å€ããéã«äœ¿çšãããŠãã
ïŒRadhakrishna A.S.ãããžã€ãŒãã«ã»ãªãã»ãª
ã«ã¬ããã¯ã»ã±ãã¹ããªãŒã44ã1746ïŒ1979ïŒïŒã çºæè ãã¯ããã®ææ³ãå¿çšãã次åŒã«åŸã€
ãŠãäžè¬åŒïŒïŒãæããæ«ç«¯âNH2åºãŸãã¯
âOHåºã§ä¿è·ããã第ïŒçŽã¢ããé žããããã
ã·é žããããããŸãã¯ããã·ããããã¢ãããã
äžè¬åŒïŒïŒã§è¡šããããâã¢ãã¢ã·ã«åãžãš
ã âãžã¢ããèªå°äœã®çžåœããããªãã«ãªãé ¢é ž
å¡©ã«çŽæ¥å€æãããããšãèŠåºããã äžèšåå¿åŒäžãã¯ãã³ãžã«ãªãã·ã«ã«ããã«
åºïŒïŒºïŒã第ïŒçŽâããã«ãªãã·ã«ã«ããã«åº
ïŒBocïŒãã¢ã·ã«æ®åºãŸãã¯äžè¬ã«åå¿æ¡ä»¶äžã§å®
å®ãªNH2ãŸãã¯OHä¿è·åºã§ãããã¯å€©ç¶ã®ã¢
ããé žãŸãã¯ããããã·é žïŒããšãã°ãããªã³ã
ã¢ã©ãã³ãããã·ã³ãã¡ããªãã³ãä¹³é žããã³ã
ã«é žãªã©ïŒãŸãã¯åæã®ã¢ããé žãŸãã¯ãããã
ã·é žïŒïŒâã¡ãã«ãããªã³ãããªãã«ãªãã¢ã©ã
ã³ãªã©ïŒã®æ®åºã§ãããã¯æ°ŽçŽ ååãŸãã¯ã¢ã«
ãã«åºãããšãã«åºãããšãã«ã¢ã«ãã¬ã³åºãã
ãããã·ããšãã«ã¢ã«ãã¬ã³åºãããããã·ã¢ã«
ãã¬ã³åºãã¢ããã¢ã«ãã¬ã³åºãã¢ã·ã«ã¢ããã¢
ã«ãã¬ã³åºãã°ã¢ããžãã«ã¢ã«ãã¬ã³åºãã€ãã
ãŸãªã«ã¢ã«ãã¬ã³åºãã€ã³ããªã«ã¢ã«ãã¬ã³åºã
ã¡ã«ã«ããã¢ã«ãã¬ã³åºãã¢ã«ãã«ã¡ã«ã«ããã¢
ã«ãã¬ã³åºãŸãã¯ã«ã«ããã·ã¢ã«ãã¬ã³åºãŸãã¯
ãããã®é©åœãªèªå°åºã§ãããïœã¯ïŒãïŒãŸãã¯
ïŒä»¥äžã§ãïŒä»¥äžã®å Žåã«ã¯ã(A)oã§è¡šãããã
ã¢ããé žã»ã¯ãšã³ã¹ã¯åäžãŸãã¯çžäºã«ç°ãªãåº
ã§æ§æãããŠããŠããããç°ãªãå Žåã«ã¯ã©ã³ã
ã ã«ãããã¯ææã®é åºã§é åãããŠããŠãã
ãããŸã(A)oã§è¡šããããã»ã¯ãšã³ã¹ã¯åäžãŸã
ã¯çžäºã«ç°ãªãã¢ããé žæ®åºããŸãã¯åäžãŸãã¯
çžäºã«ç°ãªãããããã·é žæ®åºã§æ§æãããŠããŠ
ãããããã®é åã¯ã©ã³ãã ãããã¯ææã®é åº
ã®ãããã§ãããã æ¬çºæã¯ãäžè¬çã«ã¯ãåèšäžè¬åŒïŒïŒã®ã¢
ãã³ã«æå©ã«é©çšãããåçã¯éåžž80ãªãã90ïŒ
ã§ããã åå¿ã®æé©æ¡ä»¶ãç¹ã«åå¿æéããã³è©Šè¬ã®
éãã決å®ããããã«ããã€ãããåå¿ãå©çšã
ããåæã®æº¶æ¶²ãŸãã¯æžæ¿æ¶²ãå¹æçã«æ¹æãã
ãã€åå¿æ··åç©ã«äžæŽ»æ§ã¬ã¹ãå¹èŸŒã¿ãªããåå¿
ãå®æœãããšãããåå¿ã®å®äºãŸã§ã«ã¯ïŒãªãã
ïŒæéãèŠããã åå¿çµäºåŸãæ··åç©ãèžçºä¹Ÿåºããæ®åºãé©åœ
ãªææ©æº¶åªã§æœåºããHClãšæ··åããææ©æº¶åªã«
溶解ããååŠéè«éã®HClã§åŠçããŠãçŽæ¥ã«ãŸ
ãã¯é©åœéã®ãšãã«ãšãŒãã«ãæ·»å ããããšã«ã
ããæ«ç«¯âNH2åºãŸãã¯âOHåºã§ä¿è·ããããž
ãšã âãžã¢ããèªå°äœã®å¡©é žå¡©ãçµæ¶ãšããŠåŸã
ããããã®ããã«ããŠèª¿è£œããæçµçæç©ã¯ãç
ãéã®ããããããã³ããã·ããããïŒïŒãïŒæ®
åºïŒã®å Žåã«ã¯ããã®å¡©é žå¡©ãçµæ¶åããããšã«
ããããŸãã¯ãããè€éãªããããã®å Žåã«ã¯ã
ã¯ãããã°ã©ãã€ãŒåé¢ã«ããçŽç²ãªç¶æ ã§åé¢
ããããæ«ç«¯âNH2åºãŸãã¯âOHåºã§ä¿è·ãã
ããžãšã âãžã¢ããèªå°äœã®å¡©é žå¡©ã¯ãå·åŽæ¡ä»¶
äžã§ãäžæŽ»æ§é°å²æ°äžãæžæãçããããšãªãä¿
åãããã ã¢ããé žãŸãã¯ããããèªå°äœã§ãªãã«ã«ãã
ã·ååç©ãšã®çž®ååå¿ã«ãããŠãæ«ç«¯âNH2åº
ã§ä¿è·ããããžãšã âãžã¢ããèªå°äœã䜿çšãã
å Žåã«ã€ããŠãïŒã€ã®äŸã以äžã«äŸç€ºãããçž®å
ã«é¢äžããã«ã«ããã·ã«ã¯ãéé¢ãŸãã¯ãããã
ãã©ã°ã¡ã³ãã«çµåããã¢ããé žãŸãã¯ãããã«
æ®åºãŸãã¯ïŒâ眮æãããã«æ®åºã«é¢ä¿ãããã
ããšãã°ããžãšã âãžã¢ããèªå°äœãšåèšã«ã«ã
ãã·ã«ååç©ãšã®çž®åïŒãžã·ã¯ãããã·ã«ã«ã«ã
ãžã€ããã«ããèªçºãããã€ïŒ®âããããã·ãã³
ãŸããªã¢ãŸãŒã«ã«ãã觊åªäœçšããããïŒã¯ãäž
è¬ã«ãããããåæã«ãããå ¬ç¥ã®æ¹æ³ã«ããé«
åçã§åé¢ããããæ¬çºæã®éèŠãªç¹åŸŽã®ïŒã€
ã¯ããã®æ¹æ³ããã©ã»ãåãå®è³ªçã«å®å šã«å¶åŸ¡
ããç¶æ ã§å®æœã§ããããšã«ããã ããã«é¢ããŠãé©åœã«åæãè¡ãªããã€é«å§æ¶²
äœã¯ãããã°ã©ãã€ãŒãå©çšããŠãããããã¢ã
ãBocâPheâPheâNH2ããã³BocâPheâã»
PheâNH2ã®çžåœããé¡äŒŒäœBocâPheâgPheâ
ã»HClããã³BocâPheâgDã»Pheâã»HCl
ïŒããã§gPheã¯çžåœãããžãšã âãžã¢ããPheèª
å°äœã瀺ãïŒãžã®è»¢æãå®è³ªçãªé 眮ä¿æçïŒã©
ã»ãåã®åºŠåãéåžžã®åææ³ã§ã¯æž¬å®ãåŸãªãçš
床ïŒã§è¡ãªãããããšã確èªããã æ¬çºæã®ç®çããã³ç²Ÿç¥ã¯ä»¥äžã®å®æœäŸãæ€èš
ããããšã«ããæããã«ãªãã§ãããããã ãã
ãããã®å®æœäŸã¯çã«èª¬æããããã®ãã®ã§ãã€
ãŠãæ¬çºæãå¶éãããã®ã§ã¯ãªãã ãªããçæç©ã®çŽåºŠã«ã€ããŠã¯ã以äžã®æº¶é¢å€
ç³»(1)ã䜿çšããéçžé«å§ã¯ãããã°ã©ãã€ãŒåæ
ïŒreverse phase high pressure
chromatography analysisïŒïŒRPâHPLCïŒãã
ã³ä»¥äžã®æº¶é¢å€ç³»(2)ã䜿çšããã·ãªã«ã²ã«èå±€ã«
ããã¯ãããã°ã©ãã€ãŒåæïŒTLCïŒã«ãã枬
å®ããã 溶é¢å€ç³»(1)ïŒ H2OïŒã¢ã»ããããªã«ïŒïŒ0.01M
NH4H2PO4ïŒã¢ã»ããããªã«ïŒ0.005Mããã¿
ã³ã¹ã«ãã³é žâ0.01M NH4H2PO4ïŒã¢ã»ãã
ããªã« 溶é¢å€ç³»(2)ïŒ ãã«ãã«âãã¿ããŒã«ïŒé ¢é žïŒæ°ŽïŒïŒïŒïŒïŒ
ïŒïŒïŒã¯ãããã«ã ïŒã¡ã¿ããŒã«ïŒé ¢é žïŒ85ïŒ
10ïŒïŒïŒïŒãã«ãã«âãã¿ããŒã«ïŒã€ãœããã
ããŒã«ïŒ1N NH4OHïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒ
ïŒïŒïŒïŒã®ææ©çž èç¹ïŒM.P.ïŒã«ã€ããŠã¯è£æ£ããŠããªããã¢
ããé žããã³ãã®èªå°äœã®é 眮ã¯ãæèšããŠããª
ããšããã§ã¯ïŒ¬åœ¢ã§ããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«ââããšã
ã«ã¢ã©ãã³âãžãšã âãžã¢ããââããšãã«
ã¢ã©ãã³å¡©é žå¡©ïŒBocâPheâgPheâã»
HClïŒã®åæ BocâPheâPheâNH21åœéãã¢ã»ããããªã«
âæ°ŽïŒïŒïŒïŒïŒïŒ¶ïŒïŒ¶ïŒïŒæ··åç©äžã«æžæ¿ãããå¥
ã«ã¢ã»ããããªã«äžã«æº¶è§£ããïŒïŒ©âãã¹ïŒã
ãªãã«ãªãã¢ã»ããã·ïŒãšãŒããã³ãŒïŒBTIïŒ
1.2åœéãåèšæžæ¿æ¶²ã«å®€æž©ã§æ¿ããæ¹æããªã
ãæ·»å ããã åå¿äžã«çºçããäºé žåççŽ ã®é€å»ãä¿é²ãã
ããã«ãäžæŽ»æ§ã¬ã¹ãåå¿æ··åç©äžã«å¹èŸŒãã ã
BocâPheâPheâNH2ã®æ¶å€±ã確èªããã®ã¡ã
èžçºä¹Ÿåºãããããšã«ãããBTIã®æ·»å ããçŽïŒ
æéåŸã«åå¿ãåæ¢ãããåŸãããæ®æž£ããšãã«
ãšãŒãã«ã§æŽæµãã也ç¥ããã€ãã§ãšã¿ããŒã«ã«
溶解ããããã®æº¶æ¶²ã«ãé ¢é žãšãã«ã«æº¶è§£ããå
åŠéè«éã®HClãæ·»å ããïŒæéã§BocâPheâ
gPheâã»HClã®æ²æ®¿ãå®äºããããæ²æ®¿ç©ã
åããå°éãã€ã®ãšãã«ãšãŒãã«ã§ç¹°è¿ãæŽæµ
ããæžå§äžãP2O5ã§ä¹Ÿç¥ããååããã M.P.ïŒ174âïŒdec.ïŒ ãαã546 22ïŒâ48.8°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ã
ã
äžïŒïŒ C22H30O3N3Clã«ã€ããŠã®å çŽ åæ çè«å€ïŒC62.94ïŒ ãH7.15ïŒ ãN10.01ïŒ æž¬å®å€ïŒC63.39ïŒ ãH7.12ïŒ ãN10.27ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã§ååæ§é ã確èªããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«ââããšã
ã«ã¢ã©ãã«âãžãšã âãžã¢ããââããšãã«
ã¢ã©ãã³å¡©é žå¡©ïŒBocâPheâïœââPheâ
ã»HClïŒã®åæ BocâPheââPheâNH21åœéãã¢ã»ããã
ãªã«âæ°ŽïŒïŒïŒïŒïŒïŒ¶ïŒïŒ¶ïŒïŒæ··åç©ã«æº¶è§£ããã
ã®æº¶æ¶²ã«ã宀枩ã§ãæ¿ããæ¹æããªãããã¢ã»ã
ãããªã«ã«æº¶è§£ããBTI1.2åœéãæ·»å ãããå
å¿äžã«çºçããäºé žåççŽ ã®é€å»ã容æãªãã®ãš
ããããããã®æº¶æ¶²äžã«äžæŽ»æ§ã¬ã¹ãå¹èŸŒãã ã
ïŒæéåŸãåæã¢ããã®æ¶å€±ã確èªããã®ã¡ã溶
åªæ··åç©ãçå»ããŠä¹Ÿåºãããããšã«ããåå¿ã
åæ¢ããæ®æž£ããšãã«ãšãŒãã«ã§æŽæµãã也ç¥
ãããšã¿ããŒã«ã«æº¶è§£ããããã®æº¶æ¶²ã«ãé ¢é žãš
ãã«ã«æº¶è§£ããååŠéè«éã®HClãæ·»å ãããã®
åŸãå·åŽæ¡ä»¶äžã§ãšãã«ãšãŒãã«ãé©éæ·»å ãã
ææã®çæç©ãçµæ¶ã®åœ¢ã§åŸãã M.P.ïŒ131ã133âïŒdec.ïŒ ãαã546 20ïŒ52.0°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ãã
äžïŒïŒ C22H30O3N3Clã«ã€ããŠã®å çŽ åæ çè«å€ïŒC62.94ïŒ ãH7.15ïŒ ãN10.01ïŒ æž¬å®å€ïŒC62.58ïŒ ãH7.00ïŒ ãN9.91ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã«ããååæ§é ã確èªããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«ââã¢ã©ã
ã«âãžãšã âãžã¢ããââããšãã«ã¢ã©ãã³
å¡©é žå¡©ïŒBocâAlaâgPheâã»HClïŒã®åæ BocâAlaâPheâNH21åœéãã¢ã»ããããªã«
âæ°ŽïŒïŒïŒïŒïŒïŒ¶ïŒïŒ¶ïŒïŒæ··åç©ã«æº¶è§£ãããã®æº¶
液ã«ã宀枩ã§æ¿ããæ¹æããªãããã¢ã»ããããª
ã«ã«æº¶è§£ããBTI1.2åœéãæ·»å ãããåå¿äž
ïŒçŽïŒæéïŒãåå¿å®¹åšã«äžæŽ»æ§ã¬ã¹ãäŸçµŠããçº
çããäºé žåççŽ ã®é€å»ãè¯å¥œãªãã®ãšããã
BocâAlaâPheâNH2ã®æ¶å€±ã確èªããã®ã¡ã
åå¿æº¶åªãçå»ããæ®æž£ãé ¢é žãšãã«ã«æº¶è§£ãã
é ¢é žãšãã«ã«æº¶è§£ããååŠéè«éã®HClã§åŠçã
ããåŸãããæ²æ®¿ç©ãåããå°éã®ãšãã«ãšãŒ
ãã«ã§æŽæµããæžå§äžãP2O5ã®ååšäžã§ä¹Ÿç¥ã
ãããã®çæç©ããšã¿ããŒã«ã«æº¶è§£ããããšãã«
ãšãŒãã«ãæ·»å ããå®å šã«çµæ¶åãè¡ãªããããŸ
ã§çŽïŒâã«ç¶æããããšã«ããã極埮éã®äžçŽç©
ãŸã§é€å»ããã M.P.ïŒ137âïŒdec.ïŒ ãαã546 20ïŒ37.0°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ãã
äžïŒïŒ C16H26N3O3Clã«ã€ããŠã®å çŽ åæ çè«å€ïŒC55.90ïŒ ãH7.57ïŒ ãN12.23ïŒ æž¬å®å€ïŒC55.45ïŒ ãH7.30ïŒ ãN11.05ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã«ããååæ§é ã確èªããã å®æœäŸ ïŒ ãã³ãžã«ãªãã·ã«ã«ããã«âããšãã«ã¢ã©ãã«
âãžãšã âãžã¢ããâããšãã«ã¢ã©ãã³å¡©é žå¡©
ïŒïŒºââPheâïœã»Pheâã»HClïŒã®åæ BTI1.2åœéãæ°Žâãžã¡ãã«ãã«ã ã¢ããæ··å
ç©ïŒïŒïŒïŒïŒïŒ¶ïŒïŒ¶ïŒïŒããŸãã¯ïŒïŒ ããªãã«ãªã
é ¢é žæ°Žæº¶æ¶²âãžã¡ãã«ãã«ã ã¢ããæ··åç©ïŒïŒïŒ
ïŒïŒïŒ¶ïŒïŒ¶ïŒïŒãã«æº¶è§£ããããã®æº¶æ¶²ã«ããžã¡ã
ã«ãã«ã ã¢ããã«æº¶è§£ããâPheâPheâ
NH21åœéãæ·»å ãããåå¿äžïŒçŽïŒæéïŒãäž
掻æ§ã¬ã¹ãå¹èŸŒã¿ãçæããäºé žåççŽ ã®é€å»ã
容æãªãã®ãšãããâPheâPheâNH2ã®æ¶å€±
ã確èªããã®ã¡ã溶åªæ··åç©ãçå»ããããšã«ã
ãåå¿ãåæ¢ããæ²¹ç¶æ®æž£ããšãã«ãšãŒãã«ã§æ°
åæŽæµããæžå§çã«ãããŠP2O5ã§ä¹Ÿç¥ããåã³
ã¡ã¿ããŒã«ã«æº¶è§£ãããæ°Žã«æº¶è§£ããååŠéè«é
ã®HClãæ·»å ããããšã«ãããææã®çæç©ãæ²
殿ãããããšãã«ãšãŒãã«ã§ç¹°è¿ãæŽæµããã®
ã¡ãæçµçæç©ãæžå§äžãP2O5ã§ä¹Ÿç¥ããåå
ããã M.P.ïŒ147âïŒdec.ïŒ ãαã546 20ïŒ65.2°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ãã
äžïŒïŒ C25H28N3O3Clã«ã€ããŠã®å çŽ åæ çè«å€ïŒC66.16ïŒ ãH6.17ïŒ ãN9.26ïŒ æž¬å®å€ïŒC65.80ïŒ ãH6.09ïŒ ãN9.14ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã«ããååæ§é ã確èªããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«âã¢ã©ãã«â
ãžãšã âãžã¢ããâããšãã«ã¢ã©ãã«ââã
ãšãã«ã¢ã©ãã³âãã³ãžã«ãªãã·ã«ã«ããã«
ïŒBocâAlaâgPheââPheâïŒã®åæ ââPhe1.1åœéããžã¡ãã«ãã«ã ã¢ããã«
æ·»å ãããã®æº¶æ¶²ã氷济ã§å·åŽããã€ãã§ããã®
溶液ã«ããžã¡ãã«ãã«ã ã¢ããã«æº¶è§£ããâã
ãããã·ãã³ãŸããªã¢ãŸãŒã«1.5åœéããã³ãã
ã©ããããã©ã³ã«æº¶è§£ãããžã·ã¯ãããã·ã«ã«ã«
ããžã€ãã1.1åœéãæ·»å ããã20ååŸããã®æ··
åç©ã«ãBocâAlaâgPheâã»HCl1.0åœéãã
ã³ïŒ®âã¡ãã«ã¢ã«ããªã³1.1åœéãæ·»å ãããçŽ
ïŒæéåŸã«ã氷济ãåãã¯ããããïŒæéåŸã
BocâAlaâgPheâã»HClãæ¶å€±ããŠããããš
ã確èªããã®ã¡ãåå¿æ··åç©ãéããæ®æž£ãã
ãã©ããããã©ã³ã§æŽæµããã®ã¡ãææ£ããã
液ããã³æŽæµæ¶²ãåããèžçºãããŠå®¹éçŽ10mlãš
ããéå°ã®æ°Žã§åŠçãããçœè²ã®ããŒãºç¶æ²æ®¿ã
åŸããããããåããïŒïŒ ã¯ãšã³é žæº¶æ¶²ãïŒïŒ
çé žæ°ŽçŽ ãããªãŠã 溶液ããã³æ°Žã§ç¹°è¿ãæŽæµã
ãã åŸãããçæç©ãããã©ããããã©ã³ã«æº¶è§£
ãã30ã50âç³æ²¹ãšãŒãã«ãæ·»å ããããšã«ãã
çµæ¶åããã M.P.ïŒ195ã197â ãαã546 20ïŒ9.96°ïŒïŒ£ïŒïŒïŒãžã¡ãã«ãã«ã ã¢ãã
äžïŒïŒ C33H40N4O6ã«ã€ããŠã®å çŽ åæ çè«å€ïŒC67.35ïŒ ãH6.80ïŒ ãN9.52ïŒ æž¬å®å€ïŒC67.50ïŒ ãH6.92ïŒ ãN9.38ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã§ååæ§é ã確èªããã å®æœäŸ ïŒ ç¬¬ïŒçŽâããã«ãªãã·ã«ã«ããã«âããšãã«ã¢
ã©ãã«âãžãšã âãžã¢ããââããšãã«ã¢ã©
ãã«âïœâã°ãªã·ã«âãã€ã·ã«ã¡ããªãã³ã¢ã
ãïŒBocâPheâgPheâmGlyâLeuâMetâ
NH2ïŒã®åæ HOOCâCH2âCOâLeuâMetâNH2ïŒHOâ
mGlyâLeuâMetâNH2ïŒïŒåœéãããã©ãã
ããã©ã³ã«æº¶è§£ãããã®æº¶æ¶²ã氷济ã§å·åŽããã€
ãã§ãã®æº¶æ¶²ã«ããžã¡ãã«ãã«ã ã¢ããã«æº¶è§£ã
ãâããããã·ãã³ãŸããªã¢ãŸãŒã«1.5åœéã
ãã³ããã©ããããã©ã³ã«æº¶è§£ãããžã·ã¯ããã
ã·ã«ã«ã«ããžã€ãã1.1åœéãæ·»å ããã 20ååŸããã®å·åŽããæ··åç©ã«ãBocâPheâ
gPheâã»HCl1.0åœéããã³ïŒ®âã¡ãã«ã¢ã«ã
ãªã³1.1åœéãæ·»å ãããçŽïŒæéåŸã«æ°·æµŽãå
ãå€ããæ··åç©ã宀枩ã§ïŒå€åå¿ããããæ²æ®¿ç©
ãéããããã©ããããã©ã³ã§æŽæµããã®ã¡ã
液ããã³æŽæµæ¶²ãåããçŽ10mlãšãªããŸã§æ¿çž®
ããã€ã¥ããŠéå°éã®æ°Žã§åŠçããããšã«ããã
çœè²ã®ãã¬ãŒã¯ç¶æ²æ®¿ç©ãåŸããæ²æ®¿ç©ãå
ããïŒïŒ ã¯ãšã³é žæº¶æ¶²ãïŒïŒ çé žæ°ŽçŽ ãããªãŠã
溶液ããã³æ°Žã§æŽæµãããæžå§äžãP2O5ã§ä¹Ÿç¥
ããã®ã¡ãåºç¶æ®æž£ãããã«ãšãã«ãšãŒãã«ã§æŽ
æµãã也ç¥åŸãååããã M.P.ïŒ242ã245â ãαã546 20ïŒ12.33°ïŒïŒ£ïŒ0.74ïŒãžã¡ãã«ãã«ã ã¢ã
ã
äžïŒïŒ C36H52N6O7Sã«ã€ããŠã®å çŽ åæ çè«å€ïŒC60.67ïŒ ãH7.30ïŒ ãN11.80ïŒ æž¬å®å€ïŒC60.35ïŒ ãH7.09ïŒ ãN11.69ïŒ ã¯ãããã°ã©ãã€ãŒåæïŒTLCããã³HPLCïŒ
ã§ã¯äžçŽç©ãååšããªãããšã瀺ããããŸãã
1H NMRã¹ãã¯ãã«ã«ããååæ§é ã確èªããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ ïŒåŒäžãã¯ã¢ã·ã«æ®åºã§ãããã¯å€©ç¶ãŸãã¯
åæã®ã¢ããé žãŸãã¯ããããã·é žã®æ®åºã§ã
ããã¯æ°ŽçŽ ãŸãã¯ã¢ã«ãã«åºãããšãã«åºãã
ãšãã«ã¢ã«ãã¬ã³åºãããããã·ããšãã«ã¢ã«ã
ã¬ã³åºãããããã·ã¢ã«ãã¬ã³åºãã¢ããã¢ã«ã
ã¬ã³åºãã¢ã·ã«ã¢ããã¢ã«ãã¬ã³åºãã°ã¢ããžã
ã«ã¢ã«ãã¬ã³åºãã€ãããŸãªã«ã¢ã«ãã¬ã³åºãã€
ã³ããªã«ã¢ã«ãã¬ã³åºãã¡ã«ã«ããã¢ã«ãã¬ã³
åºãã¢ã«ãã«ã¡ã«ã«ããã¢ã«ãã¬ã³åºãŸãã¯ã«ã«
ããã·ã¢ã«ãã¬ã³åºãŸãã¯ãããã®èªå°åºã§ã
ããïœã¯ïŒãïŒãŸãã¯ïŒä»¥äžã§ãããïŒä»¥äžã®å Ž
åã«ã¯ãã»ã¯ãšã³ã¹(A)oã¯åäžãŸãã¯çžäºã«ç°ãª
ãæ®åºã§æ§æãããŠããŠãããïŒãæããâã¢
ãã¢ã·ã«åãžãšã âãžã¢ããèªå°äœã®è£œæ³ã«ãã
ãŠãäžè¬åŒ ïŒåŒäžããAnãããã³ïŒ²ã¯åèšãšåæ矩ã§ã
ãïŒ ãæããã¢ãããããâãã¹ïŒããªãã«ãªã
ã¢ã»ããã·ïŒã¢ãšãŒããã³ãŒã³ãšåå¿ãããããš
ãç¹åŸŽãšãããâã¢ãã¢ã·ã«åãžãšã âãžã¢ã
ãèªå°äœã®è£œæ³ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT25755/81A IT1195304B (it) | 1981-12-22 | 1981-12-22 | Metodo per la preparazione di gem-diammino derivati n-monoacilati |
| IT25755A/81 | 1981-12-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58146538A JPS58146538A (ja) | 1983-09-01 |
| JPH0377178B2 true JPH0377178B2 (ja) | 1991-12-09 |
Family
ID=11217640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57224104A Granted JPS58146538A (ja) | 1981-12-22 | 1982-12-22 | âã¢ãã¢ã·ã«åãžãšã âãžã¢ããèªå°äœã®è£œæ³ |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0084691A1 (ja) |
| JP (1) | JPS58146538A (ja) |
| IT (1) | IT1195304B (ja) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1188206B (it) * | 1985-11-28 | 1988-01-07 | Eniricerche Spa | Procedimento per la sintesi in fase solida di peptidi in cui almeno un legame ammidico e' retroinvertito |
| IT1228451B (it) * | 1989-02-22 | 1991-06-19 | Sclavo S P A Siena | Nuovi derivati diamminici geminali e loro impiego nelle sintesi di peptidi retro-inversi |
| US20040082509A1 (en) | 1999-10-12 | 2004-04-29 | Christophe Bonny | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| US6610820B1 (en) * | 1999-10-12 | 2003-08-26 | University Of Lausanne | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| US8183339B1 (en) | 1999-10-12 | 2012-05-22 | Xigen S.A. | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| WO2007031098A1 (en) | 2005-09-12 | 2007-03-22 | Xigen S.A. | Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| US8080517B2 (en) | 2005-09-12 | 2011-12-20 | Xigen Sa | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| WO2009143864A1 (en) | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
| WO2009143865A1 (en) | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| WO2010072228A1 (en) | 2008-12-22 | 2010-07-01 | Xigen S.A. | Novel transporter constructs and transporter cargo conjugate molecules |
| WO2011160653A1 (en) | 2010-06-21 | 2011-12-29 | Xigen S.A. | Novel jnk inhibitor molecules |
| WO2012048721A1 (en) | 2010-10-14 | 2012-04-19 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases |
| WO2013091670A1 (en) | 2011-12-21 | 2013-06-27 | Xigen S.A. | Novel jnk inhibitor molecules for treatment of various diseases |
| KR20160023669A (ko) | 2013-06-26 | 2016-03-03 | ììŽê² ìžíëŒë©ìŽì 늬믞í°ë | ë€ìí ì§ë³ì ì¹ë£ë¥Œ ìí jnk ì íž ì ë¬ ê²œë¡ì ìží¬ í¬ê³Œì± í©íìŽë ìµì ìì ìë¡ìŽ ì©ë |
| WO2014206427A1 (en) | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| WO2015197097A1 (en) | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
-
1981
- 1981-12-22 IT IT25755/81A patent/IT1195304B/it active
-
1982
- 1982-12-16 EP EP82201611A patent/EP0084691A1/en not_active Withdrawn
- 1982-12-22 JP JP57224104A patent/JPS58146538A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IT8125755A0 (it) | 1981-12-22 |
| IT1195304B (it) | 1988-10-12 |
| JPS58146538A (ja) | 1983-09-01 |
| EP0084691A1 (en) | 1983-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0377178B2 (ja) | ||
| US4927809A (en) | Oligopeptidyl nitrile derivatives, agents containing them and their use | |
| US5977302A (en) | Liquid phase process for the preparation of GnRH peptides | |
| FI79329C (fi) | Nytt foerfarande foer framstaellning av pentapeptiden h-arg-x-asp-y-tyr-r och vid foerfarandet anvaenda mellanprodukter. | |
| EP0122818B1 (fr) | SynthÚse du hpGRF (Somatocrinine) en phase liquide et peptides intermédiaires | |
| US4638046A (en) | Retro-inverso C-terminal hexapeptide analogues of substance P | |
| US4725645A (en) | Process for synthesising peptides | |
| US6184345B1 (en) | Branched building units for synthesizing cyclic peptides | |
| JPS63250360A (ja) | ãµã€ã¢ãã³ãã³ã¬ããâã€ã³ããŒãœé¡äŒŒäœåã³ãã®ãã©ã°ã¡ã³ã | |
| Ciardelli et al. | Des-N-tetramethyltriostin A and bis-L-seryldes-N-tetramethyltriostin A, synthetic analogs of the quinoxaline antibiotics | |
| JPS6317839B2 (ja) | ||
| EP0171315B1 (fr) | Procédé de synthÚse du hGRF (Somatocrinine) en phase liquide et peptides intermédiaires | |
| US4691008A (en) | Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs, and new intermediates for this process | |
| EP0452514A1 (en) | Peptide and process for preparing cyclic peptide | |
| US4491541A (en) | Peptides | |
| EP0181121B1 (en) | Novel polypeptide and process for producing the same | |
| JPWO1991007433A1 (ja) | ãããããããã³ç°ç¶ããããã®è£œé æ¹æ³ | |
| WO1992001709A1 (en) | Process for synthesizing peptides | |
| JPS5818345A (ja) | ç°ç¶ãããµããããã®è£œæ³ | |
| IL105036A (en) | Method and intermediates for peptide synthesis containing one or more carbamoyl groups | |
| US3247178A (en) | Synthesis of peptides containing alpha, omega-diamino acids protected by phthalyl and t-butyloxycarbonyl groups | |
| EP0406931B1 (en) | New analogues of all-bond retroinverted thymopentin, the method for the synthesis of the same and their employment for the preparation of pharmaceutical compositions | |
| EP1348714B1 (en) | Polypeptide useful as anti-allergic/antiasthmatic, methods for the preparation thereof and pharmaceutical compositions containing such polypeptide and their use | |
| US5219988A (en) | Gem-diamino derivatives and their use in the synthesis of retro-inverso peptides | |
| JPH07316193A (ja) | ããããèªå°äœããã³ãã®çšé |